Balchem (NASDAQ:BCPC) posted its earnings results on Tuesday, February 27th. The basic materials company reported $0.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.06, Bloomberg Earnings reports. Balchem had a net margin of 15.14% and a return on equity of 14.16%. The business had revenue of $159.26 million for the quarter.
Balchem (BCPC) traded down $0.95 on Wednesday, hitting $81.42. 98,548 shares of the stock traded hands, compared to its average volume of 110,199. The company has a market cap of $2,638.84, a P/E ratio of 29.52 and a beta of 1.05. Balchem has a one year low of $70.23 and a one year high of $88.47. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.84 and a quick ratio of 1.28.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Schroder Investment Management Group grew its position in shares of Balchem by 9.5% during the 3rd quarter. Schroder Investment Management Group now owns 97,154 shares of the basic materials company’s stock valued at $7,958,000 after buying an additional 8,463 shares during the last quarter. Bessemer Group Inc. grew its position in shares of Balchem by 83.2% during the 3rd quarter. Bessemer Group Inc. now owns 31,700 shares of the basic materials company’s stock valued at $2,577,000 after buying an additional 14,400 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in shares of Balchem by 4.0% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 48,636 shares of the basic materials company’s stock valued at $3,920,000 after buying an additional 1,890 shares during the last quarter. Santa Monica Partners LP bought a new stake in shares of Balchem during the 4th quarter valued at about $43,548,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of Balchem by 3.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 62,343 shares of the basic materials company’s stock valued at $4,845,000 after buying an additional 2,024 shares during the last quarter. 88.89% of the stock is owned by institutional investors.
Separately, BidaskClub lowered shares of Balchem from a “sell” rating to a “strong sell” rating in a report on Friday, December 22nd.
COPYRIGHT VIOLATION WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://ledgergazette.com/2018/03/14/balchem-bcpc-releases-earnings-results-beats-estimates-by-0-06-eps.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.